Augustin Boudry

9PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Liquid biopsiesMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 23, 2026
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

|May 28, 2026
Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Sep 03, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia.

Augustin Boudry, Laure Goursaud, Delphine Lebon

|Oct 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia.

Romane Joudinaud, Augustin Boudry, Laurène Fenwarth

Pageof 2

Frequent Collaborators

8 joint publications

Nicolas Duployez

6 joint publications

Laurene Fenwarth

6 joint publications

Raphaël Itzykson

4 joint publications

Christian Récher